NeuroBo Pharmaceuticals' Da-1241 in Combination With Semaglutide Improves Liver Fibrosis and Demonstrates Additive Hepatoprotective Effects in Pre-Clinical Mash Models Compared to Either Treatment, Alone
與單獨使用任何一種治療相比，NeuroBo Pharmaceuticals的Da-1241與索瑪魯肽聯合使用可改善肝纖維化，並在臨床前混合模型中顯示出額外的保肝作用